![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Open Orphan Plc | LSE:ORPH | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.00 | 9.50 | 10.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
30/1/2021 21:13 | If this is correct surely its massive 🤷a A 10 minute resulted test 98% + accurate & cheap as chips | ![]() bobdobalina | |
30/1/2021 21:12 | Saliva not nasal swab, that's a bonus. | ![]() chopsy | |
30/1/2021 20:27 | #ORPH #BTNX IMHO Game-Changing news yet to be RNSed. These test kits change the antigen testing landscape. These kits are CE marked with very high accuracy results in rapid time. | elrico | |
30/1/2021 19:14 | Interesting bit of bonus news if proven true. | ![]() mark10101 | |
30/1/2021 18:56 | Woah - why don't we have an RNS on this??! | ![]() king suarez | |
30/1/2021 18:43 | £10 per test, 25 tests in a kit. Very affordable. | ![]() gregb | |
30/1/2021 18:17 | Wow Surely that’s big news? | ![]() judijudi | |
30/1/2021 17:00 | Great research here. Not mine. With thanks to Eskers. Interesting post by Maurice Treacy (Orph director) on LinkedIn today.... | ![]() m5 | |
30/1/2021 09:49 | #ORPH Challenge studies | elrico | |
30/1/2021 08:09 | “Are they all equally effective? It is hard to compare one company's results with another as their trials will have been conducted in slightly different ways and at points in the pandemic. However, all the main vaccines seem to have a large impact on your chances of needing hospital treatment or dying from Covid. However, one of the most important questions - do they stop you spreading the virus - remains unknown. Understanding which method produces the best results will be explored in challenge trials where people are deliberately infected with the virus. What drugs can help treat coronavirus?” | ![]() mark10101 | |
29/1/2021 22:39 | It’s underwritten. They would not do this without “a plan” What it is ;?who knows but it’s significant given the size | jimzi | |
29/1/2021 20:44 | Biondvax raising money with what looks like a boilerplate "No current commitments or agreements" statement regarding acquisitions. I suppose that might not rule out them being in advanced negotiations to allow orph to reverse (non-core assets) in, and conceivably some of the cash could be to allow them to pay ORPH a cash sweetener to secure a deal. The second statement below would perhaps cover a potential deal with either ORPH or ConserV. "The Company may also use a portion of any net proceeds to in-license, invest in or acquire businesses, assets or technologies that BiondVax believes are complementary to its business focus, although BiondVax has no current commitments or agreements in those regards." "The company is now pursuing opportunities in the infectious disease space, including exploring several alternatives for development of a pipeline of assets." | ![]() 1gw | |
29/1/2021 20:19 | Melvin Capital lost 5 billion | ![]() malcolmmm | |
29/1/2021 17:23 | What I am looking for in CFs interview next week is a clue to which big RNS is coming first, can he keep himself from not giving us a clue? Dont think so. The one I want is the wearables which I believe is going to transform the company into a data lead one which is what he said we would be this year, imagine challenge studies being secondary to data? Think about that for a minute and how much money he is thinking about there. I try not to post these days but its after hours Friday no harm in a bit of speculation :0) | ![]() pogue | |
29/1/2021 16:19 | Well I can definitely say I have had better weeks on the markets. I do hope that CF can put a bit of spark under the sp, because we sure could do with it. Good weekend all. | ![]() m5 | |
29/1/2021 16:14 | Yeah they're all buys today ... that's why the share price has fallen 4%Get real, face reality and accept that these shares are being dumped in blocks | ![]() 12toes | |
29/1/2021 16:07 | As they are all delayed quite a few are actually buys. Main trades are delayed from the day before, posted after close, however even those have shown buys and sells. | ![]() troutisout | |
29/1/2021 15:53 | The big seller is dumping into any buys, I've noted 30000, 50000, 60000 blocks over the last few weeks, always in 000s | ![]() 12toes | |
29/1/2021 15:52 | Unfortunately it won't do anything for the share price until the big seller is out | ![]() 12toes | |
29/1/2021 15:17 | AJ Bell are hosting Orph webcast next Wednesday. If CF is in normal form then should inspire the share price | nashwan123 | |
29/1/2021 13:26 | Just had a look : Spreadex only taking sells atm. Its existing book shows as 100% long. | ![]() extrader | |
29/1/2021 13:16 | 1gw29 Jan '21 - 12:19 - 11122 of 11123 I would agree with that. I am sure a lot of people will be listening to CF next week. Certainly news is due on various fronts and looking back to the last presentation and guidance given by CF it does not want to be stretched too much longer. Maybe we will get some news prior to his presentation. That would not surprise me whatsoever. I think February is going to be a big month for us. | ![]() m5 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions